BRAND_ANALYSIS #ILLUMINA HEALTH & PHARMA #5 OF 26 IN HEALTH & PHARMA INTERESTING

Illumina

· Public · Updated 09 Apr 2026 08:47 UTC
#44 of 1208 overall by tension · #5 of 26 in Health & Pharma
28 Interesting
The Silent Giant
Analysis

Gene-sequencing monopolist coasting on B=68 while culture sleeps at C=40. Up 2.99% but invisible at rank #44, Illumina represents capital's favorite trick: world-changing technology with zero cultural footprint. The 28-point tension gap is what happens when your customers are labs, not people.

IN THE NEWS (33 articles this week)
Illumina Announces Changes to Board of Directors - PR Newswire
The Evolving Landscape of Proteomics: HUPO World Congress Interview with Professor Stuart Cordwell - Illumina
The Bull Case For Illumina (ILMN) Could Change Following A Board Refresh Centered On Regulatory Expertise - simplywall.st
Cultural Score
40 / 100
Business Score
68 / 100
TENSION▂▂▂▂▂▂▂▂▁▁▂▂▂▂
CULTURAL▃▄▄▄▄▄▄▃▄▄▄▄▃▃
BUSINESS▅▅▆▅▅▅▅▅▄▅▅▅▅▅
Loading...
Wikipedia Momentum 15/40
News Presence 26/35
Search InterestRedistributed to other dimensions
Stock Momentum 20/30
Market Position 16/25
Revenue Growth 15/25
Earnings Health 17/20
Price$128.00
30d Change+3.0%
Market Cap$19.6B
Profit Margin19.6%
Illumina's tension is 28. Commerce outpacing culture. sociologyofcapitalism.com/brand/illumina
SHARE ON X
EMBED
<iframe src="https://sociologyofcapitalism.com/embed/illumina.html" width="320" height="200" frameborder="0"></iframe>